| 1 |
patient-derived xenograft
(1965 times)
|
Neoplasms
(988 times)
|
TNBC (106 times)
PDAC (81 times)
HCC (78 times)
|
2012 Integrated preclinical and clinical development of S-trans, trans-Farnesylthiosalicylic Acid (FTS, Salirasib) in pancreatic cancer.
|
| 2 |
polydextrose
(60 times)
|
Nutritional Sciences
(34 times)
|
GOS (17 times)
SCFAs (4 times)
FOS (3 times)
|
2004 Combination of polydextrose and lactitol affects microbial ecosystem and immune responses in rat gastrointestinal tract.
|
| 3 |
protectin DX
(33 times)
|
Biochemistry
(6 times)
|
DHA (9 times)
AMPK (8 times)
PD1 (4 times)
|
2013 Characterization and biological effects of di-hydroxylated compounds deriving from the lipoxygenation of ALA.
|
| 4 |
pancreatic duodenal homeobox
(23 times)
|
Endocrinology
(10 times)
|
STZ (2 times)
ADM (1 time)
ALX (1 time)
|
2000 Interleukin-1beta-induced alteration in a beta-cell phenotype can reduce cellular sensitivity to conditions that cause necrosis but not to cytokine-induced apoptosis.
|
| 5 |
patient-derived pancreatic cancer xenografts
(10 times)
|
Neoplasms
(6 times)
|
DOX (2 times)
c-Myc (1 time)
Cdc25C (1 time)
|
2015 Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy.
|
| 6 |
patient-derived xenotransplantation
(6 times)
|
Hematology
(3 times)
|
AML (1 time)
HA (1 time)
HAS3 (1 time)
|
2016 Patient-derived xenotransplants can recapitulate the genetic driver landscape of acute leukemias.
|
| 7 |
polydioxanone
(6 times)
|
Biocompatible Materials
(2 times)
|
AV (1 time)
DX (1 time)
ECM (1 time)
|
1987 Polydioxanone or polypropylene for closure of midline abdominal incisions: a prospective comparative clinical trial.
|
| 8 |
patient's tumor derived xenograft
(4 times)
|
Neoplasms
(3 times)
|
SCPC (2 times)
AR (1 time)
AVPC (1 time)
|
2015 Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer.
|
| 9 |
podocalyxin
(4 times)
|
Nephrology
(3 times)
|
FSGS (3 times)
MCD (1 time)
MPGN (1 time)
|
2008 Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases.
|
| 10 |
pyridoxine
(4 times)
|
Neurology
(3 times)
|
STM (2 times)
WS (2 times)
DRG (1 time)
|
2002 Add-on treatment with pyridoxine and sulthiame in 12 infants with West syndrome: an open clinical study.
|
| 11 |
breast-cancer-patient-tissue-derived xenograft
(2 times)
|
Proteome
(1 time)
|
FMT (1 time)
MS (1 time)
NIR (1 time)
|
2015 An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer.
|
| 12 |
paradoxin
(2 times)
|
Neurology
(2 times)
|
AML (1 time)
CTX (1 time)
sPLA2 (1 time)
|
1998 Secreted phospholipase A2-induced neurotoxicity and epileptic seizures after intracerebral administration: an unexplained heterogeneity as emphasized with paradoxin and crotoxin.
|
| 13 |
patient tissue derived xenograft
(2 times)
|
Nanotechnology
(1 time)
|
NIR (2 times)
BSA (1 time)
CT (1 time)
|
2016 IGF-1 receptor targeted nanoparticles for image-guided therapy of stroma-rich and drug resistant human cancer.
|
| 14 |
patient-derived explant
(2 times)
|
Nanomedicine
(1 time)
|
alpha-SMA (1 time)
ApTDCs (1 time)
CT (1 time)
|
2020 High-resolution 3D visualization of nanomedicine distribution in tumors.
|
| 15 |
patient-derived samples and xenograft
(2 times)
|
Biological Science Disciplines
(1 time)
|
BCs (1 time)
BCSC (1 time)
ERs (1 time)
|
2015 Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity.
|
| 16 |
potential control and divertor simulating experiment
(2 times)
|
Biomedical Engineering
(1 time)
|
DR (1 time)
|
2023 Ku-band multichannel frequency comb Doppler reflectometer on the GAMMA 10/potential control and divertor simulating experiment (PDX) tandem mirror.
|
| 17 |
1-PDX
(1 time)
|
Science
(1 time)
|
HNSCC (1 time)
MMPs (1 time)
|
2001 Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells.
|
| 18 |
patient derived colon carcinoma xenografts
(1 time)
|
Neoplasms
(1 time)
|
CPE (1 time)
optCPE (1 time)
|
2017 Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy.
|
| 19 |
patient derived human melanoma xenotransplant
(1 time)
|
Molecular Biology
(1 time)
|
---
|
2014 Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector.
|
| 20 |
patient-derived acute myeloid leukemia xenotransplantation
(1 time)
|
Hematology
(1 time)
|
alpha-KG (1 time)
R-2HG (1 time)
|
2016 Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate.
|
| 21 |
patient-derived cell line and xenograft
(1 time)
|
Neoplasms
(1 time)
|
METex14 (1 time)
NSCLC (1 time)
WT (1 time)
|
2018 Amplification of Wild-type KRAS Imparts Resistance to Crizotinib in MET Exon 14 Mutant Non-Small Cell Lung Cancer.
|
| 22 |
patient-derived cell lines in an orthotopic xenograft model in mice
(1 time)
|
Biomedical Engineering
(1 time)
|
PDAC (1 time)
|
2016 A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
|
| 23 |
patient-derived organoid-based xenograft
(1 time)
|
Neoplasms
(1 time)
|
NGS (1 time)
PDO (1 time)
RTKs (1 time)
|
2022 A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma.
|
| 24 |
patient-derived organoids andpatient derived xenografts
(1 time)
|
Natural Science Disciplines
(1 time)
|
CLOs (1 time)
PDAC (1 time)
|
2020 Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development.
|
| 25 |
patient-derived ovarian adenocarcinoma xenografts
(1 time)
|
Rheumatology
(1 time)
|
TSP-1 (1 time)
|
2015 Expression of thrombospondin-1 by tumor cells in patient-derived ovarian carcinoma xenografts.
|
| 26 |
patient-derived Sezary cells xenotransplanted
(1 time)
|
Hematologic Diseases
(1 time)
|
SS (1 time)
|
2022 Sezary syndrome patient-derived models allow drug selection for personalized therapy.
|
| 27 |
patient-derived subcutaneous tumor xenografts
(1 time)
|
Cell Transformation, Neoplastic
(1 time)
|
COPD (1 time)
LC (1 time)
lncRNA (1 time)
|
2023 Mechanism of lnRNA-ICL involved in lung cancer development in COPD patients through modulating microRNA-19-3p/NKRF/NF-κB axis.
|
| 28 |
Patient-Derived Xenografts from Solid Tumors
(1 time)
|
Molecular Biology
(1 time)
|
---
|
2021 Patient-Derived Xenografts from Solid Tumors (PDX) for Models of Metastasis.
|
| 29 |
patients.Patient-derived xenograft
(1 time)
|
Neoplasms
(1 time)
|
BPH (1 time)
DFS (1 time)
PCa (1 time)
|
2018 TMEM45B is a novel predictive biomarker for prostate cancer progression and metastasis.
|
| 30 |
PDAC xenograft models
(1 time)
|
Neoplasms
(1 time)
|
AOA (1 time)
BPTES (1 time)
CQ (1 time)
|
2017 Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin.
|
| 31 |
PDMs derived from surgical specimens were established as xenografts
(1 time)
|
Urologic Diseases
(1 time)
|
PDMs (1 time)
|
2022 Patient derived models of bladder cancer enrich the signal of the tumor cell transcriptome facilitating the analysis of the tumor cell compartment.
|
| 32 |
podocyte detection method using podocalyxin
(1 time)
|
Cell Biology
(1 time)
|
WT1 (1 time)
|
2022 Urinary Podocyte Count as a Potential Routine Laboratory Test for Glomerular Disease: A Novel Method Using Liquid-Based Cytology and Immunoenzyme Staining.
|
| 33 |
podocyte diagnostics is podocalyxin
(1 time)
|
Nephrology
(1 time)
|
IgA (1 time)
|
2012 Relationship between urinary podocytes and kidney diseases.
|
| 34 |
Point density exclusion
(1 time)
|
|
ICE (1 time)
|
2021 Point density exclusion mapping-A useful tool for mapping arrhythmias arising from the endocavitary structures.
|
| 35 |
porcine dermal matrix
(1 time)
|
Dentistry
(1 time)
|
---
|
2014 Porcine dermal matrix in the treatment of dehiscence-type defects--an experimental split-mouth animal trial.
|
| 36 |
postnatal dexamethasone
(1 time)
|
Pediatrics
(1 time)
|
ADX (1 time)
ELBW (1 time)
|
2002 Association of antenatal and postnatal dexamethasone exposure with outcomes in extremely low birth weight neonates.
|
| 37 |
predict the response of an organism as a whole.Patient-derived xenograft
(1 time)
|
Molecular Biology
(1 time)
|
---
|
2018 Development of Patient-Derived Tumor Xenograft Models.
|
| 38 |
primary and metastatic tumor xenografts
(1 time)
|
Biological Science Disciplines
(1 time)
|
CRC (1 time)
mCRC (1 time)
|
2019 PCK1 and DHODH drive colorectal cancer liver metastatic colonization and hypoxic growth by promoting nucleotide synthesis.
|
| 39 |
primary breast tumor-derived xenografts
(1 time)
|
Neoplasms
(1 time)
|
CSC (1 time)
|
2013 ALDH1-positive cancer stem cells predict engraftment of primary breast tumors and are governed by a common stem cell program.
|
| 40 |
primary cells isolated from triple-negative breast cancer-derived xenografts
(1 time)
|
Biochemistry
(1 time)
|
IGF-1R (1 time)
PROCR (1 time)
|
2017 Protein C receptor stimulates multiple signaling pathways in breast cancer cells.
|
| 41 |
Primary Derived Xenograft
(1 time)
|
Chemistry
(1 time)
|
TNBC (1 time)
|
2022 Multi-Level Control of the ATM/ATR-CHK1 Axis by the Transcription Factor E4F1 in Triple-Negative Breast Cancer.
|
| 42 |
primary leukemia cells and xenografts derived thereof
(1 time)
|
Natural Science Disciplines
(1 time)
|
GOI (1 time)
|
2021 A reporter system for enriching CRISPR/Cas9 knockout cells in technically challenging settings like patient models.
|
| 43 |
primary tissue mediated xenograft
(1 time)
|
Cell Communication
(1 time)
|
ABCG2 (1 time)
CSCs (1 time)
CUR (1 time)
|
2022 Quinacrine and Curcumin in combination decreased the breast cancer angiogenesis by modulating ABCG2 via VEGF A.
|
| 44 |
propagated as xenografts
(1 time)
|
Neoplasms
(1 time)
|
DLDA (1 time)
GBM (1 time)
MV (1 time)
|
2018 Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.
|
| 45 |
pyridoxalphosphate
(1 time)
|
Medicine
(1 time)
|
INH (1 time)
|
1989 [Inhibition of porphyrin synthesis by isonicotinic acid hydrazide in models simulating porphyria].
|
| 46 |
Pyridoxine biosynthesis
(1 time)
|
Natural Science Disciplines
(1 time)
|
SOS4 (1 time)
VitB6 (1 time)
|
2019 Bacillus subtilis CBR05 induces Vitamin B6 biosynthesis in tomato through the de novo pathway in contributing disease resistance against Xanthomonas campestris pv. vesicatoria.
|
A Search Service for Abbreviation / Long Form